The Centers for Disease Control and Prevention (CDC) has recommended clinicians and patients immediately discontinue the use of EzriCare Artificial Tears, an over-the-counter eye drop. The CDC issued a statement stating that recent epidemiology and laboratory evidence linked various infections with the drops. Patient outcomes from case-patient testing include permanent vision loss resulting from ocular infection, hospitalization, and death of one patient with a bloodstream infection.
If you or someone you know has suffered an infection following the use of EzriCare Artificial Tears, contact us. Our product liability attorneys have decades of experience fighting large corporations in dangerous medical device litigation and getting people compensation for their injuries. We can provide you with a no-cost case evaluation. Contact our Pharmaceutical Drug and Medical Device attorneys now.